Sinovac Biotech Ltd. (SVA)
Market Closed
16 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
6. 47
0
0%
$
464.94M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 6.47
Previous Close Want to track SVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sinovac Biotech Ltd. (SVA) Statistics
Valuation metrics
Market Cap 464.94M
Enterprise value -184.52M
Trailing P/E (ttm) -7.8
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 1.2
Price/Book (mrq) 0.1
Enterprise Value/Revenue -0.48
Enterprise Value/EBITDA 0.98
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 6.47
52-Week high 6.47
Beta -
50-Day moving average 6.47
200-Day moving average 6.47
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.15%
Operating margin -0.75%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 5.37
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 92.39
Total debt (mrq) -
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 4.59%
Book value per share (mrq) 89.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
